Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Phase Distribution

Ph early_phase_1

20%

Ph not_applicable

40%

Ph phase_2

20%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Early Phase 1First-in-human

1(20.0%)

Phase 1Safety & dosage

1(20.0%)

Phase 2Efficacy & side effects

1(20.0%)

N/ANon-phased studies

2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Detailed Status

Completed3

Not yet recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Early Phase 11 (20.0%)

Phase 11 (20.0%)

Phase 21 (20.0%)

N/A2 (40.0%)

Trials by Status

completed360%

not_yet_recruiting120%

recruiting120%

Recent Activity

1 active trials

Showing 5 of 5

not_yet_recruitingearly_phase_1

Swallowable Cannabigerol Tablets for Sleep Quality In Veterans (Veterans Exploring Cannabigerol for Sleep)

NCT05088018

Clinical Trials (5)

Showing 5 of 5 trials

NCT07577999Early Phase 1

The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy

Not Yet Recruiting

NCT05257044Phase 1

Acute Effects of Cannabigerol

Completed

NCT06115603Phase 2

The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder

Recruiting

NCT05743985Not Applicable

Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults

Completed

NCT05088018Not Applicable

Swallowable Cannabigerol Tablets for Sleep Quality In Veterans (Veterans Exploring Cannabigerol for Sleep)

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5